{
    "paper_id": "449a4b7b716fca8b205ee4ede84769419f15ed32",
    "metadata": {
        "title": "Corresponding author(s): Experimental design 1. Sample size",
        "authors": [
            {
                "first": "Simon",
                "middle": [],
                "last": "Jochems",
                "suffix": "",
                "affiliation": {},
                "email": ""
            },
            {
                "first": "Helder",
                "middle": [],
                "last": "Nakaya",
                "suffix": "",
                "affiliation": {},
                "email": ""
            },
            {
                "first": "Daniela",
                "middle": [],
                "last": "Ferreira",
                "suffix": "",
                "affiliation": {},
                "email": ""
            }
        ]
    },
    "abstract": [
        {
            "text": "Nature Research wishes to improve the reproducibility of the work that we publish. This form is intended for publication with all accepted life science papers and provides structure for consistency and transparency in reporting. Every life science submission will use this form; some list items might not apply to an individual manuscript, but all fields must be completed for clarity.",
            "cite_spans": [],
            "ref_spans": [],
            "section": "Abstract"
        },
        {
            "text": "Describe how sample size was determined.",
            "cite_spans": [],
            "ref_spans": [],
            "section": "Abstract"
        },
        {
            "text": "With baseline carriage rates of 50% (expected based on prior data from our model), 73 participants in each arm were required for 80% power to detect a 50% relative increase in pneumococcal acquisition at any time point, after 10% drop-out.",
            "cite_spans": [],
            "ref_spans": [],
            "section": "Abstract"
        },
        {
            "text": "Describe any data exclusions.",
            "cite_spans": [],
            "ref_spans": [],
            "section": "Abstract"
        },
        {
            "text": "Of 130 vaccinated volunteers, five were natural pneumococcal carriers (two in LAIV arm and three in control arm) and were excluded from further analysis. Another 8 subjects in the LAIV arm were excluded following a systematic LAIV dispensing error by a single practitioner, as recommended by the trial steering group. This resulted in a final 55 subjects analysed in the LAIV arm and 62 subjects in the control arm.",
            "cite_spans": [],
            "ref_spans": [],
            "section": "Abstract"
        },
        {
            "text": "Describe the measures taken to verify the reproducibility of the experimental findings.",
            "cite_spans": [],
            "ref_spans": [],
            "section": "Abstract"
        },
        {
            "text": "Key findings, including monocyte recruitment to the nasopharynx were validated in an independent patient cohort. All attempts are replication findings were successful.",
            "cite_spans": [],
            "ref_spans": [],
            "section": "Abstract"
        },
        {
            "text": "Describe how samples/organisms/participants were allocated into experimental groups.",
            "cite_spans": [],
            "ref_spans": [],
            "section": "Abstract"
        },
        {
            "text": "Using a permuted-block algorithm (1:1, blocks of 10) held in sealed envelopes, participants were randomised to receive either nasal LAIV (Fluenz Tetra or FluMist Tetra, AstraZeneca, UK, used interchangeably due to procurement shortages) paired with intramuscular placebo (0.5ml normal saline), or nasal placebo [control] (0.2ml normal saline) paired with intramuscular Quadrivalent Inactivated Influenza Vaccination (Fluarix Tetra, GlaxoSmithKline, UK) (see supplemental methods for flu strains).",
            "cite_spans": [],
            "ref_spans": [],
            "section": "Abstract"
        },
        {
            "text": "Describe whether the investigators were blinded to group allocation during data collection and/or analysis.",
            "cite_spans": [],
            "ref_spans": [],
            "section": "Abstract"
        },
        {
            "text": "This was a double-blinded, randomized trial where investigators were blinded during data collection and data analysis Note: all in vivo studies must report how sample size was determined and whether blinding and randomization were used.",
            "cite_spans": [],
            "ref_spans": [],
            "section": "Abstract"
        }
    ],
    "body_text": [
        {
            "text": "Nature Research wishes to improve the reproducibility of the work that we publish. This form is intended for publication with all accepted life science papers and provides structure for consistency and transparency in reporting. Every life science submission will use this form; some list items might not apply to an individual manuscript, but all fields must be completed for clarity.",
            "cite_spans": [],
            "ref_spans": [],
            "section": "Life Sciences Reporting Summary"
        },
        {
            "text": "For further information on the points included in this form, see Reporting Life Sciences Research. For further information on Nature Research policies, including our data availability policy, see Authors & Referees and the Editorial Policy Checklist.",
            "cite_spans": [],
            "ref_spans": [],
            "section": "Life Sciences Reporting Summary"
        },
        {
            "text": "Please do not complete any field with \"not applicable\" or n/a. Refer to the help text for what text to use if an item is not relevant to your study. For final submission: please carefully check your responses for accuracy; you will not be able to make changes later.",
            "cite_spans": [],
            "ref_spans": [],
            "section": "Life Sciences Reporting Summary"
        },
        {
            "text": "Experimental design 1. Sample size Describe how sample size was determined.",
            "cite_spans": [],
            "ref_spans": [],
            "section": "Life Sciences Reporting Summary"
        },
        {
            "text": "With baseline carriage rates of 50% (expected based on prior data from our model), 73 participants in each arm were required for 80% power to detect a 50% relative increase in pneumococcal acquisition at any time point, after 10% drop-out.",
            "cite_spans": [],
            "ref_spans": [],
            "section": "Life Sciences Reporting Summary"
        },
        {
            "text": "Describe any data exclusions.",
            "cite_spans": [],
            "ref_spans": [],
            "section": "Data exclusions"
        },
        {
            "text": "Of 130 vaccinated volunteers, five were natural pneumococcal carriers (two in LAIV arm and three in control arm) and were excluded from further analysis. Another 8 subjects in the LAIV arm were excluded following a systematic LAIV dispensing error by a single practitioner, as recommended by the trial steering group. This resulted in a final 55 subjects analysed in the LAIV arm and 62 subjects in the control arm.",
            "cite_spans": [],
            "ref_spans": [],
            "section": "Data exclusions"
        },
        {
            "text": "Describe the measures taken to verify the reproducibility of the experimental findings.",
            "cite_spans": [],
            "ref_spans": [],
            "section": "Replication"
        },
        {
            "text": "Key findings, including monocyte recruitment to the nasopharynx were validated in an independent patient cohort. All attempts are replication findings were successful.",
            "cite_spans": [],
            "ref_spans": [],
            "section": "Replication"
        },
        {
            "text": "Describe how samples/organisms/participants were allocated into experimental groups.",
            "cite_spans": [],
            "ref_spans": [],
            "section": "Randomization"
        },
        {
            "text": "Using a permuted-block algorithm (1:1, blocks of 10) held in sealed envelopes, participants were randomised to receive either nasal LAIV (Fluenz Tetra or FluMist Tetra, AstraZeneca, UK, used interchangeably due to procurement shortages) paired with intramuscular placebo (0.5ml normal saline), or nasal placebo [control] (0.2ml normal saline) paired with intramuscular Quadrivalent Inactivated Influenza Vaccination (Fluarix Tetra, GlaxoSmithKline, UK) (see supplemental methods for flu strains).",
            "cite_spans": [],
            "ref_spans": [],
            "section": "Randomization"
        },
        {
            "text": "Describe whether the investigators were blinded to group allocation during data collection and/or analysis.",
            "cite_spans": [],
            "ref_spans": [],
            "section": "Blinding"
        },
        {
            "text": "This was a double-blinded, randomized trial where investigators were blinded during data collection and data analysis Note: all in vivo studies must report how sample size was determined and whether blinding and randomization were used.",
            "cite_spans": [],
            "ref_spans": [],
            "section": "Blinding"
        },
        {
            "text": "November 2017",
            "cite_spans": [],
            "ref_spans": [],
            "section": "nature research | life sciences reporting summary"
        },
        {
            "text": "For all figures and tables that use statistical methods, confirm that the following items are present in relevant figure legends (or in the Methods section if additional space is needed).",
            "cite_spans": [],
            "ref_spans": [],
            "section": "Statistical parameters"
        },
        {
            "text": "The exact sample size (n) for each experimental group/condition, given as a discrete number and unit of measurement (animals, litters, cultures, etc.) A description of how samples were collected, noting whether measurements were taken from distinct samples or whether the same sample was measured repeatedly A statement indicating how many times each experiment was replicated",
            "cite_spans": [
                {
                    "start": 116,
                    "end": 150,
                    "text": "(animals, litters, cultures, etc.)",
                    "ref_id": null
                }
            ],
            "ref_spans": [],
            "section": "n/a Confirmed"
        },
        {
            "text": "The statistical test(s) used and whether they are one-or two-sided Only common tests should be described solely by name; describe more complex techniques in the Methods section.",
            "cite_spans": [],
            "ref_spans": [],
            "section": "n/a Confirmed"
        },
        {
            "text": "A description of any assumptions or corrections, such as an adjustment for multiple comparisons",
            "cite_spans": [],
            "ref_spans": [],
            "section": "n/a Confirmed"
        },
        {
            "text": "Provide confidence intervals or give results of significance tests (e.g. P values) as exact values whenever appropriate and with effect sizes noted.",
            "cite_spans": [],
            "ref_spans": [],
            "section": "Test values indicating whether an effect is present"
        },
        {
            "text": "A clear description of statistics including central tendency (e.g. median, mean) and variation (e.g. standard deviation, interquartile range)",
            "cite_spans": [],
            "ref_spans": [],
            "section": "Test values indicating whether an effect is present"
        },
        {
            "text": "See the web collection on statistics for biologists for further resources and guidance.",
            "cite_spans": [],
            "ref_spans": [],
            "section": "Clearly defined error bars in all relevant figure captions (with explicit mention of central tendency and variation)"
        },
        {
            "text": "Policy information about availability of computer code",
            "cite_spans": [],
            "ref_spans": [],
            "section": "Software"
        },
        {
            "text": "Describe the software used to analyze the data in this study. .0a was used to align RNA-Seq read featureCounts v1.5.2 was used to extract numbers of mapped reads from aligned RNAseq data FastQC v0.11.5 was used for RNA-Seq QC analysis MultiQC v1.1 was used for RNA-Seq QC analysis Flowjo v10 was used for analysing flow cytometry data",
            "cite_spans": [],
            "ref_spans": [],
            "section": "Software"
        },
        {
            "text": "The following R packages were used: DESeq2 v1.14.1 was used to perform differential gene expression analysis from Nanostring and RNA-Seq data Cemitool v0.99.9 was used for co-expression analysis from gene expression data For manuscripts utilizing custom algorithms or software that are central to the paper but not yet described in the published literature, software must be made available to editors and reviewers upon request. We strongly encourage code deposition in a community repository (e.g. GitHub). Nature Methods guidance for providing algorithms and software for publication provides further information on this topic.",
            "cite_spans": [],
            "ref_spans": [],
            "section": "Software"
        },
        {
            "text": "Policy information about availability of materials 8. Materials availability Indicate whether there are restrictions on availability of unique materials or if these materials are only available for distribution by a third party.",
            "cite_spans": [],
            "ref_spans": [],
            "section": "Materials and reagents"
        },
        {
            "text": "No unique materials were developed or used for this study 9. Antibodies Describe the antibodies used and how they were validated for use in the system under study (i.e. assay and species). The volunteers were healthy young adults",
            "cite_spans": [],
            "ref_spans": [],
            "section": "Materials and reagents"
        }
    ],
    "bib_entries": {
        "BIBREF0": {
            "ref_id": "b0",
            "title": "Biolegend catalogue #302012, 1:20 dilution CD66b-FITC, clone G10F5, Biolegend catalogue #305104, 1:20 dilution CD3-APCH7, clone SK7, BD catalogue #560176, 1:33 dilution CD14-PercpCy5.5, clone M\u03c6P9, BD catalogue #562692, 1:20 dilution CD45-PACOrange, clone HI30",
            "authors": [
                {
                    "first": "-Pe",
                    "middle": [],
                    "last": "Epcam",
                    "suffix": ""
                }
            ],
            "year": 2017,
            "venue": "Biolegend catalogue #324206, 1:20 dilution HLADR-PECy7, clone L243, Biolegend catalogue #307616, 1:20 dilution CD16-APC, clone 3G8",
            "volume": "",
            "issn": "",
            "pages": "",
            "other_ids": {
                "DOI": [
                    "10.1371/journal.pone.0169805"
                ]
            }
        }
    },
    "ref_entries": {
        "FIGREF0": {
            "text": "any of the cell lines used are listed in the database of commonly misidentified cell lines maintained by ICLAC, provide a scientific rationale for their use. no eukaryotic cell lines were used Animals and human research participants Policy information about studies involving animals; when reporting animal research, follow the ARRIVE guidelines 11. Description of research animals Provide all relevant details on animals and/or animal-derived materials used in the study. No animals were used Policy information about studies involving human research participants 12. Description of human research participants Describe the covariate-relevant population characteristics of the human research participants. Age (median + range) = 20 (18-48); Female gender no (%) = 79 (58.9); Mean pneumococcus inoculation dose in CFU (sd) = 75699 (8478);",
            "latex": null,
            "type": "figure"
        }
    },
    "back_matter": []
}